E-cadherin is recognized as an important prognostic marker that facilitates improved risk stratification, allowing for more tailored treatment approaches for patients with GC.15 To our knowledge, there are no previous studies having looked at E-cadherin expression in Zambia. The gene discussed is CDH1; the disease is gastric cancer.